Neuropsychiatric Symptoms in HIV Patients after Switching from Nevirapine to Dolutegravir in Cipto Mangunkusumo Hospital, Jakarta

Introduction. Dolutegravir (DTG) is one of the effective antiretroviral therapies (ART) for suppressing HIV replication and has a favorable safety profile. However, reports regarding neuropsychiatric side effects, especially in patients transitioning from a nevirapine (NVP) regimen to dolutegravir,...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Metra Adi Pratama, Rudi Putranto, Herqutanto Herqutanto, Aisyah Syahrani, Veritea Natali, Aljira Fitya Hapsari, Meivina Ramadhani Pane, Evy Yunihastuti
Materiálatiipa:	Artigo
Giella:	Indonésio
Almmustuhtton:	Department of Internal Medicine, Faculty of Medicine Universitas Indonesia 2025-06-01
Ráidu:	Jurnal Penyakit Dalam Indonesia
Fáttát:	arv art dolutegravir hiv neuropsychiatric nevirapine
Liŋkkat:	https://scholarhub.ui.ac.id/jpdi/vol12/iss2/4/
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!